MedTrace Logo

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer

NCT01889615 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2016-10-06

No results posted yet for this study

Summary

The investigators want to compare the use of MRI with PET/CT preformed after 1 hour and 3 hours in preoperative assessment of resectability.

The investigators' hypothesis is that dual time PET/CT performed at 60 and 180 minutes will increase the diagnostic accuracy of conventional PET (performed at 60 minutes) in preoperative assessment of resectability.

Further more the investigators suggest that the GLUT/G6Pase index correlates to the SUVmax. And retention index (RI, see Methods - PET protocol) is a prognostic marker in ovarian cancer.

Conditions

Interventions

OTHER

PET/CT(3hours]

Low dose PET/CT 1 and 3 hours after injection of FDG, followed by a diagnostic CT with iv contrast

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Mie H Vilstrup, MD · Department of Nuclear Medicine, Odense University Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01889615 on ClinicalTrials.gov